BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23393360)

  • 21. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26).
    Reiter E; Greinix H; Rabitsch W; Keil F; Schwarzinger I; Jaeger U; Lechner K; Worel N; Streubel B; Fonatsch C; Mitterbauer G; Kalhs P
    Ann Hematol; 2000 Jul; 79(7):374-7. PubMed ID: 10965785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
    Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA
    Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
    Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
    Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.
    De Braekeleer M; Le Bris MJ; De Braekeleer E; Basinko A; Morel F; Douet-Guilbert N
    Future Oncol; 2015; 11(11):1675-86. PubMed ID: 26043219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
    Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
    Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
    Theil KS; Cotta CV
    Cancer Genet; 2014 May; 207(5):171-6. PubMed ID: 25027637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
    Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
    Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
    Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
    Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
    Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
    Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies.
    Shi G; Weh HJ; Dührsen U; Zeller W; Hossfeld DK
    Cancer Genet Cytogenet; 1997 Jul; 96(1):58-63. PubMed ID: 9209472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
    Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute panmyelosis with myelofibrosis with EVI1 amplification.
    Grygalewicz B; Woroniecka R; Pastwińska A; Rygier J; Krawczyk P; Borg K; Makuch-Łasica H; Patkowska E; Pieńkowska-Grela B
    Cancer Genet; 2012 May; 205(5):255-60. PubMed ID: 22682625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia.
    Wieser R; Lechner K; Valent P; Fonatsch C
    Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000
    [No Abstract]   [Full Text] [Related]  

  • 37. Rearrangements of chromosome band 3q21 in myeloid leukemia.
    Wieser R
    Leuk Lymphoma; 2002 Jan; 43(1):59-65. PubMed ID: 11908737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of cases with chromosome 3q21q26 aberrations].
    Zhang Y; He Q; Shi Y; Dang H; Qiu JY; Huang XJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):22-5. PubMed ID: 18315893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification of 3q21q26 syndrome by "multipoint" interphase FISH analyses in childhood myeloid leukemia].
    Haltrich I; Kost-Alimova M; Kovács G; Kriván G; Dobos M; Imreh S; Fekete G
    Magy Onkol; 2005; 49(2):141-7. PubMed ID: 16249810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.